About

Medicine begins as a crystal. So do we.

Polymorra exists because the step that decides whether a drug substance is releasable — crystallization — is the least autonomous step in the entire pharmaceutical supply chain.

$24BTAM estimate
$6BSAM estimate
$360MSOM estimate

Built for the plants that make the world’s small molecules

  • Branded pharma
  • Generics
  • CDMOs
  • Fine chemicals
  • Peptide APIs
  • High-potency APIs
  • Continuous plants

Why now

Three curves finally crossed

In-line PAT became standard in new API plants, edge GPUs became cheap enough to sit beside a crystallizer, and foundation models became good enough to reason over spectra, images, and documents together.

  • PAT instrumentation is already installed and underused
  • Edge inference is affordable at the train level
  • Multi-modal models can fuse spectra, images, and telemetry
  • Regulators now expect continuous process verification

What we believe

Autonomy has to be earned, in public

Nobody hands control of a GMP batch to software on a promise. So we built the audit trail before the autopilot, the shadow mode before the control loop, and the validation package before the sales deck.

  • Perception first, control second
  • Every output cited to its evidence
  • Quality is a design input, not a compliance afterthought

Why it matters

The API plant is the most valuable, least autonomous step in pharma

7autonomous agents from charge to release
4PAT modalities fused in-line (Raman · FBRM · PVM · NIR)
24billion-dollar TAM across API automation and control
134% net revenue retention target as plants expand

Market figures are internal estimates from our TAM/SAM/SOM analysis. Product performance figures are design targets. [ASPIRATIONAL]

The autonomous loop

Perceive, plan, act, sense, optimize, log

Polymorra closes the loop around the reaction mass and the crystal — the two things a conventional DCS cannot actually see.

  1. Perceive

    Fuse Raman, FBRM, PVM in-situ imaging, NIR, and reactor telemetry into a live picture of the reaction mass, slurry, and solids.

  2. Plan

    Plan the react-and-charge, crystallize-and-seed, and isolate-and-dry moves for this batch against the target polymorph, particle size, and purity.

  3. Act

    Run with adaptive control: cooling and antisolvent profile, seeding, supersaturation, agitation, addition rate, and endpoint.

  4. Sense & predict

    Predict polymorph, particle size and habit, impurity profile, and yield in-line — before offline XRPD and HPLC confirm it.

  5. Optimize

    Optimize yield, solvent use, cycle time, and reprocessing risk across the campaign, then flag off-spec and polymorph risk early.

  6. Log & retrain

    Write an immutable Part 11 record; every chemist correction trains the site model and compounds the data moat.

Roadmap

Where we are going

Directional, and marked as such. [ASPIRATIONAL]

  1. Now

    Crystallization wedge

    Perception and assist-mode control on crystallizer trains with design partners.

  2. Next

    Full plant loop

    Reaction, isolation, drying, and review by exception across every train in a site.

  3. Then

    Twin-led tech transfer

    Lab-to-plant crystallization prediction as a standard part of route introduction.

  4. Later

    Network autonomy

    Fleet-level optimization across sites, with models that improve everywhere as each plant corrects them.

How we work

Principles we actually apply

Walk the plant

Every feature starts at a train with a chemist, not in a backlog.

Learn more

Mark the claim

Aspirational statements are labelled. Estimates are labelled. Trust compounds.

Learn more

Fail safe

If we are unsure, the DCS keeps control and the batch continues.

Learn more

Small and deep

A few design partners with real engineering attention beats a wide pilot graveyard.

Learn more

Accelerated computing

An NVIDIA-accelerated stack, from the train to the fleet

Perception at the edge, reasoning in the cloud, and a reactor-and-crystallizer twin in between.

Stack

Jetson at the train

Plant-edge inference per reactor or crystallizer train: PVM crystal-image models, FBRM feature extraction, Raman and NIR soft sensors, anomaly and safety classifiers. [ASPIRATIONAL]

Stack

TensorRT + Holoscan

Low-latency perception and sensor-stream preprocessing for in-situ imaging and PAT spectra inside validated control windows.

Stack

Triton + NIM

Route-specific polymorph, impurity, particle-size, endpoint, and batch-reasoning models served with validated version locks and rollback.

Stack

Omniverse + Cosmos

Reactor-and-crystallizer twin plus synthesis of rare crystallization faults — oiling-out, fouling, seed drift, wrong-polymorph nucleation. [ASPIRATIONAL]

Stack

RAPIDS + cuOpt

Telemetry ETL at campaign scale, plus scheduling, solvent recovery, and crystallization-profile optimization.

Stack

NeMo + DGX

Fine-tuned chemistry-process and batch-record reasoning trained on de-identified design-partner data and chemist corrections. [ASPIRATIONAL]

Trust & compliance

Validated for GMP manufacturing

Polymorra is engineered for regulated drug-substance production: grounded outputs, immutable audit trails, graduated autonomy, and validation documentation from day one.

21 CFR Part 11

Immutable, validated audit log for every agent perception, recommendation, and control action, with e-signature-ready review flows.

GMP / ICH Q7

Change control, validated model versioning, and deployment documentation designed for drug-substance manufacturing.

SOC 2

SOC 2 Type I in progress, Type II on the roadmap; SSO/RBAC, encryption in transit and at rest. [ASPIRATIONAL]

Route & IP protection

Per-tenant isolation of routes, recipes, spectra, and crystal images. No cross-tenant training. On-prem option.

Graduated autonomy

Shadow → assist → bounded auto-control. Every autonomy level is explicitly configured, bounded, and revocable.

Grounded outputs

Every recommendation cites the spectra, images, telemetry, SOP, or specification it was derived from.

Plant-edge first

Inference runs on-site so control loops survive network loss; cloud is for training, fleet, and analytics.

Human-in-the-loop

Chemist and QA checkpoints are first-class: approve, correct, or reject — and every correction trains the models.

Voices from the plant

What operators say

Composite quotes from design-partner discovery interviews. [PLACEHOLDER — to be replaced with named references post-pilot]

“The crystallization step is where our campaigns live or die. Seeing supersaturation, particle size, and predicted polymorph in one place — and having the profile adjust itself — is what we have wanted for twenty years.”
Crystallization & PAT EngineerTop-20 branded pharma · API site
“We do not want another dashboard. We want the batch to come out right and the record to be reviewable by exception. That is the only pitch that gets past QA.”
QA / Regulatory ManagerGeneric API manufacturer
“Tech transfer is our bottleneck. If the twin can predict the plant crystal from the lab crystal, that is worth more than the software costs.”
API Manufacturing DirectorGlobal CDMO

Build the plant that runs itself.

Start with one crystallizer or reactor train. Prove polymorph, yield, and reprocessing ROI in a validation-friendly pilot. Then expand across the plant.